Tazocilline and alanine aminotransferase increased Patient Reports February 13, 2012

Tazocilline Side Effects Report #4927923-9
Tazocilline side effect was reported by a Consumer or non-health professional from FRANCE on Feb 13, 2006. Male patient, 34 years of age, was diagnosed with pneumonia  and was treated with Tazocilline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest pain , disseminated intravascular coagulation, dyspnoea, fibrin d dimer increased, neutropenia, platelet count decreased. Tazocilline dosage: unknown. During the same period patient was treated with CIFLOX. Patient was hospitalized. Patient recovered.

Tazocilline Side Effects Report #4998587-3
Tazocilline side effect was reported by a Consumer or non-health professional from FRANCE on May 04, 2006. Male patient, 34 years of age, was diagnosed with pneumonia  and was treated with Tazocilline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest pain , dyspnoea, fibrin d dimer increased, neutropenia, platelet count decreased, pyrexia. Tazocilline dosage: unknown. During the same period patient was treated with CIFLOX. Patient was hospitalized. Patient recovered.

Tazocilline Side Effects Report #4745010-X
Tazocilline side effect was reported by a Consumer or non-health professional from FRANCE on Aug 04, 2005. Female patient, 19 years of age, was diagnosed with ear infection  and was treated with Tazocilline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood triglycerides increased, histiocytosis haematophagic, hyperthermia, lymphocyte morphology abnormal, pruritus. Tazocilline dosage: unknown. During the same period patient was treated with AMIKIN. Patient was hospitalized. Patient recovered.